Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Curis (CRIS) Cash & Equivalents (2016 - 2025)

Curis' Cash & Equivalents history spans 16 years, with the latest figure at $5.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 74.69% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $5.1 million, down 74.69%, while the annual FY2025 figure was $5.1 million, 74.69% down from the prior year.
  • Cash & Equivalents reached $5.1 million in Q4 2025 per CRIS's latest filing, down from $9.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $111.0 million in Q1 2021 to a low of $5.1 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $30.5 million, with a median of $22.7 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: surged 785.98% in 2021, then plummeted 83.37% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $40.0 million in 2021, then tumbled by 50.87% to $19.7 million in 2022, then soared by 35.73% to $26.7 million in 2023, then fell by 25.05% to $20.0 million in 2024, then plummeted by 74.69% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for CRIS's Cash & Equivalents are $5.1 million (Q4 2025), $9.1 million (Q3 2025), and $10.1 million (Q2 2025).